FOXA
56
3
TRIP
52
3
BEN
50
2
KEY
43
-3
AIG
50
2
SRE
50
5
URI
65
-5
DVA
75
-2
SIG
47
-3
A
39
2
OI
42
4
PSX
47
-3
ZBH
65
2
BLK
57
-4
LRCX
42
-3
TXN
43
-3
COST
63
-3
ZTS
54
7
PVH
64
-3
ORCL
55
-10
FOXA
56
3
TRIP
52
3
BEN
50
2
KEY
43
-3
AIG
50
2
SRE
50
5
URI
65
-5
DVA
75
-2
SIG
47
-3
A
39
2
OI
42
4
PSX
47
-3
ZBH
65
2
BLK
57
-4
LRCX
42
-3
TXN
43
-3
COST
63
-3
ZTS
54
7
PVH
64
-3
ORCL
55
-10
Financhill
Back

Range Cancer Therapeutics ETF Vs. SPDR® S&P Pharmaceuticals ETF Industry Stock Comparison

Buy
54

CNCR
Range Cancer Therapeutics ETF

Last Price:
14.00
Seasonality Move:
2.55%
Buy
63

XPH
SPDR® S&P Pharmaceuticals ETF

Last Price:
46.38
Seasonality Move:
5.85%
Buy
54
Range Cancer Therapeutics ETF (CNCR) is a Buy

Is Range Cancer Therapeutics ETF a Buy, Sell or Hold?

  • The current Range Cancer Therapeutics ETF [CNCR] share price is $14.19. The Score for CNCR is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • CNCR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
63
SPDR® S&P Pharmaceuticals ETF (XPH) is a Buy

Is SPDR® S&P Pharmaceuticals ETF a Buy, Sell or Hold?

  • The current SPDR® S&P Pharmaceuticals ETF [XPH] share price is $46.28. The Score for XPH is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • XPH is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CNCR Stock Price Chart

What is Range Cancer Therapeutics ETF's stock price today?

  • The Range Cancer Therapeutics ETF share price today is $14.19
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNCR is experiencing buying pressure, which is a positive indicator for future bullish movement.

XPH Stock Price Chart

What is SPDR® S&P Pharmaceuticals ETF's stock price today?

  • The SPDR® S&P Pharmaceuticals ETF share price today is $46.28
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XPH is experiencing slight buying pressure.

CNCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.35 Sell
Relative Strength Index (14 RSI): 47.36 Sell
Chaikin Money Flow: 4099 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.71 - 15.35) Sell
Bollinger Bands (100): (14.11 - 15.45) Sell

XPH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 51.56 Buy
Chaikin Money Flow: 6498 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (45.5 - 47.22) Sell
Bollinger Bands (100): (42.56 - 46.1) Buy

CNCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.6 Buy
20-day SMA: 14.43 Sell
50-day SMA: 14.76 Sell
200-day SMA: 15.02 Sell
8-day EMA: 13.87 Buy
20-day EMA: 14.22 Sell
50-day EMA: 14.57 Sell
200-day EMA: 14.54 Sell

XPH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.81 Buy
20-day SMA: 46.4 Sell
50-day SMA: 45.68 Buy
200-day SMA: 42.89 Buy
8-day EMA: 46.07 Buy
20-day EMA: 46.16 Buy
50-day EMA: 45.62 Buy
200-day EMA: 43.37 Buy

Range Cancer Therapeutics ETF Earnings Growth & CNCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

SPDR® S&P Pharmaceuticals ETF Earnings Growth & XPH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Range Cancer Therapeutics ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

SPDR® S&P Pharmaceuticals ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):